Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
This report summarizes a completed 5-year longitudinal study examining brain atrophy in individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial [Phase 4]
A Phase 4 pilot trial evaluating Rebif (interferon beta-1a) with advanced MRI and immunology endpoints in multiple sclerosis has completed, …
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Whole Body Vibration Therapy in Participants With MS Related Balance Deficits [NA]
This entry notes the completion of a clinical trial evaluating whole body vibration therapy for balance deficits in people with Multiple Scl…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis [Phase 2, Phase 3]
A completed Phase 2/3 safety trial evaluating the combination of Avonex (interferon beta-1a) and CellCept (mycophenolate mofetil) in patient…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial examining the pathophysiology and treatment of demyelination in multiple sclerosis was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-19FDA Approved: REBIF — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for Rebif (interferon beta-1a) submitted by EMD Serono, Inc.
-
CLINICAL_TRIALS withdrawal · 2013-04-18Clinical Trial Update: Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA) [NA]
Clinical trial evaluating CPAP treatment for fatigue in patients with multiple sclerosis and obstructive sleep apnea has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Effects of Vaporized Marijuana on Neuropathic Pain [Phase 1, Phase 2]
Phase 1/2 trial investigating vaporized marijuana for neuropathic pain has completed with results posted in 2013.
-
FDA approval · 2013-03-27FDA Approved: TECFIDERA — Original Application (Biogen Inc.)
FDA granted approval of Tecfidera (dimethyl fumarate) from Biogen for the treatment of relapsing forms of multiple sclerosis.
-
FDA approval · 2013-03-19FDA Approved: ZANAFLEX — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for ZANAFLEX (tizanidine hydrochloride) from Covis Pharma US, Inc.
-
FDA approval · 2013-03-13FDA Approved: AVONEX — Supplemental Application (Biogen Inc.)
The FDA approved a supplemental application for AVONEX (interferon beta-1a) submitted by Biogen.
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: The Effects of Attention Retraining in MS
This is a completed clinical trial evaluating attention retraining for individuals with multiple sclerosis.
-
FDA approval · 2013-03-08FDA Approved: ZANAFLEX — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Zanaflex (tizanidine hydrochloride) submitted by Covis Pharma US, Inc., updating the labelin…
-
FDA approval · 2013-03-08FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for COPAXONE (glatiramer acetate) submitted by Teva Neuroscience, Inc.
-
FDA approval · 2013-03-06FDA Approved: LIORESAL (BACLOFEN) — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Lioresal (baclofen) from Amneal Pharmaceuticals LLC, enabling changes to the product labeling fo…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Teleconference Fatigue Management for People With Multiple Sclerosis [NA]
Completed clinical trial evaluating teleconference-based fatigue management for people with Multiple Sclerosis; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide [Phase 2]
Phase 2 trial evaluating the immune response to the influenza vaccine in multiple sclerosis patients treated with teriflunomide; results hav…
-
FDA approval · 2013-02-22FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for COPAXONE (glatiramer acetate) from Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis [Phase 1]
A Phase 1 trial comparing the safety and immunologic effects of low-dose versus high-dose vitamin D3 in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Effects of Vestibular Rehabilitation on MS-related Fatigue: a Randomized Control Trial [NA]
This document reports the completion of a randomized controlled trial evaluating vestibular rehabilitation for MS-related fatigue. Balance a…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Therapy Optimization in Multiple Sclerosis (MS)
This document provides an update on a completed clinical trial evaluating therapy optimization for multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Neuroprotection and Repair in Optic Neuritis [Phase 2]
Phase 2 trial investigating neuroprotection and repair in optic neuritis was terminated. Conditions include multiple sclerosis and optic neu…
-
FDA approval · 2013-01-22FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
The FDA approved a supplemental application for Ampyra (dalfampridine) by Merz Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Management of Pain in Persons With Multiple Sclerosis [NA]
This clinical trial update notes the completion of a study on managing pain in persons with multiple sclerosis.
-
CLINICAL_TRIALS research · 2013-01-15Clinical Trial Update: Vitamine D in Multiple Sclerosis [Phase 3]
Phase 3 clinical trial evaluating Vitamin D for Multiple Sclerosis. The current status of the trial is unknown.